Eli Lilly and Company
LYSOPHOSPHATIDIC ACID RECEPTOR 1 (LPAR1) INHIBITOR COMPOUNDS
Last updated:
Abstract:
The present invention provides a compound of formula (I) or a pharmaceutical salt thereof, use, methods for its preparation are described. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
28 Aug 2018
Issue date:
23 Jul 2020